receptor in Murine atherogenesis. receptor altered inflammatory cytokine expression in vivo or inflammatory cell adhesion in the flow chamber in vitro. does not appear to be a suitable therapeutic target for reduction of the atherosclerotic plaque
Background: Calcification of atherosclerotic plaques is associated with vulnerability to rupture an...
Atherosclerosis is a chronic inflammatory disorder of medium and large vessels. Immune signaling and...
Atherosclerosis and its major adverse cardiovascular events, heart disease and stroke, are the leadi...
BACKGROUND:Strong evidence supports a protective role of the cannabinoid receptor 2 (CB(2)) in infla...
In the last decades, the cannabinoid system (comprising synthetic and endogenous cannabinoid agonist...
In the last decades, the cannabinoid system (comprising synthetic and endogenous cannabinoid agonist...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
Atherosclerosis is a macrophage-dominated nonresolving inflammatory disease of the arterial wall. Ma...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
The activation of cannabinoid receptor type 2 (CB(2))-mediated pathways might represent a promising ...
Objective: To determine if cannabinoid receptor 2 (CB2) plays a role in atherosclerosis, we investig...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
PURPOSE: WIN55,212-2, a potent synthetic agonist of cannabinoid receptor type 1 (CB1) and cannabinoi...
Abstract Aims. The activation of cannabinoid receptor type 2 (CB(2))-mediated pathways might repres...
Our current understanding of the pathophysiology of atherosclerosis suggests a prominent role for im...
Background: Calcification of atherosclerotic plaques is associated with vulnerability to rupture an...
Atherosclerosis is a chronic inflammatory disorder of medium and large vessels. Immune signaling and...
Atherosclerosis and its major adverse cardiovascular events, heart disease and stroke, are the leadi...
BACKGROUND:Strong evidence supports a protective role of the cannabinoid receptor 2 (CB(2)) in infla...
In the last decades, the cannabinoid system (comprising synthetic and endogenous cannabinoid agonist...
In the last decades, the cannabinoid system (comprising synthetic and endogenous cannabinoid agonist...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
Atherosclerosis is a macrophage-dominated nonresolving inflammatory disease of the arterial wall. Ma...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
The activation of cannabinoid receptor type 2 (CB(2))-mediated pathways might represent a promising ...
Objective: To determine if cannabinoid receptor 2 (CB2) plays a role in atherosclerosis, we investig...
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction...
PURPOSE: WIN55,212-2, a potent synthetic agonist of cannabinoid receptor type 1 (CB1) and cannabinoi...
Abstract Aims. The activation of cannabinoid receptor type 2 (CB(2))-mediated pathways might repres...
Our current understanding of the pathophysiology of atherosclerosis suggests a prominent role for im...
Background: Calcification of atherosclerotic plaques is associated with vulnerability to rupture an...
Atherosclerosis is a chronic inflammatory disorder of medium and large vessels. Immune signaling and...
Atherosclerosis and its major adverse cardiovascular events, heart disease and stroke, are the leadi...